Small Molecules

15 May 2007 Luitpold Pharmaceuticals, Inc., Announces NDA Submission for Injectafer (Ferric Carboxymaltose Injection), a Next Generation Intravenous Iron Product
15 May 2007 Momenta Pharmaceuticals Initiates Phase I Clinical Study for M118 Subcutaneous Formulation
15 May 2007 Critical Therapeutics' Sales Force Gains Access to a Second Product as FDA Approves Co-Promotion Partner's New Treatment for COPD
15 May 2007 Skyepharma PLC and Sciele Pharma Announce Successful Completion of New Sular(R) Formulation Clinical Trial Programme
15 May 2007 Avicena Initiates Phase I Clinical Trial in Amyotrophic Lateral Sclerosis (ALS)
15 May 2007 BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl
15 May 2007 CV Therapeutics Submits New Drug Application For Regadenoson
15 May 2007 AlphaRx and Proprius Pharmaceuticals Announce Top Line Results from Indaflex(TM) Phase II Study in Canada
15 May 2007 GSK Returns Development Rights for MED2002
12 May 2007 NicOx Provides An Update On The Phase 2a Study For NCX 1000 Conducted With Axcan
12 May 2007 Merck Receives Approvable Letter from FDA for EMEND(R) (fosaprepitant dimeglumine) For Injection
11 May 2007 FDA Approves Schwarz Pharma's Neupro (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
11 May 2007 ZIOPHARM Treats First Patient in Phase II ZIO-101 Liver Cancer Trial
11 May 2007 Manhattan Pharmaceuticals Successfully Completes Dosing Portion of Two Phase 2a Clinical Trials of Oral Oleoyl-estrone for Obesity
11 May 2007 Molecular Insight Pharmaceuticals, Inc. Initiates Azedra(TM) Therapeutic Trial in Neuroendocrine Cancer Patients
10 May 2007 Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats
10 May 2007 Curis Provides Update on Hedgehog Agonist Hair Growth Program
10 May 2007 IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
10 May 2007 Tapestry Pharmaceuticals Announces Phase II Clinical Program for TPI 287
10 May 2007 Somaxon Pharmaceuticals Provides Update on Silenor Development Program
09 May 2007 4SC AG Provides Proof of Concept for Drug Candidate SC75741 in the Treatment of Influenza A-infected Mice
09 May 2007 Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
09 May 2007 Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
09 May 2007 ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
08 May 2007 Adverse event with oral EPO FG-2216 in anemia treatment

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up